An analog of Ac-SDKP improves heart functions after myocardial infarction by suppressing alternative activation (M2) of macrophages

Int J Cardiol. 2014 Aug 1;175(2):376-8. doi: 10.1016/j.ijcard.2014.05.016. Epub 2014 May 15.

¹ State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.
² Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
³ State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China. Electronic address: [email protected].
⁴ Department of Pharmacogenomics, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China. Electronic address: [email protected].

No abstract available

Keywords: Analog; Anti-fibrosis; Macrophage; Myocardial Infarction; Peptide.

Publication types